Sort
50,496 grants matching “lung cancer”
TUMOR HETEROGENEITY AND THERAPEUTIC RESISTANCE IN SMALL CELL LUNG CANCER SCLC
$559,999The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2018 · Department of the Army
Comparative Biomedical Scientist Training Program
$559,987Robert Simpson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies
$559,987Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Occupational and Environmental Determinants of Cancer among Women and Minorities
$559,959Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Photodynamic Therapy of Disseminated Peritoneal Tumor Using New Photosensitizers
$559,864Waheguru P Singh · Lynntech, Inc. · R44 · FY2009 · CA
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
The interplay of social and molecular determinants in lung cancer disparity
$559,834Shailesh Singh · Morehouse School Of Medicine · R01 · FY2024 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$559,834David P Carbone · Ohio State University · R01 · FY2022 · CA
Taxi STEP (Social networks, Technology, and Exercise through Pedometers)
$559,809Francesca M Gany · Sloan-Kettering Inst Can Research · U01 · FY2017 · MD
(7) Novel imaging devices for measurement and control of tumor microenvironments
$559,773John S Condeelis · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$559,763Melissa J Suter · Massachusetts General Hospital · R01 · FY2013 · CA
NEW THERAPEUTICS TARGETING MYC AND IMMUNE ESCAPE IN LUNG CANCER
$559,756Baylor College Of Medicine · · FY2022 · Defense Health Agency
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$559,729Jiang He · University Of Virginia · R01 · FY2020 · CA
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
$559,725Rong Huang · Purdue University · R01 · FY2022 · CA
Local Flavor Policies to Enhance Equity in Tobacco
$559,632Shyanika W Rose · University Of Kentucky · R01 · FY2023 · CA
Project-003
$559,613Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2020 · CA
Small molecule probes of MYC stability and function intumorigenesis
$559,511Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2022 · CA
Small molecule probes of MYC stability and function intumorigenesis
$559,511Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2023 · CA
Lung cancer molecular markers by sex: intergroup study
$559,505Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Highly Multiplexed Digital Assays
$559,408Mark S. Chee · Prognosys Biosciences, Inc. · R44 · FY2015 · GM
Nanotechnologies for Comprehensive Single Cancer Cell Analysis
$559,357Stephen R Quake · Stanford University · U54 · FY2011 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$559,327Sidi Chen · Yale University · R01 · FY2019 · CA
Probing RAS-mediated Signaling with Monobody Inhibitors
$559,309John P O'Bryan · Medical University Of South Carolina · R01 · FY2024 · CA
Chemoprevention of Tobacco Related Cancer in Animals
$559,283Ohio State University · R01 · FY2004 · CA